All In MedTech

FDA Clearance Tracker · P030017-S277

PRECISION SPINAL CORD STIMULATION(SCS) SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 8, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 8, 2017

Approved

Time to decision

221 days

Received Jan 30, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030017-S277
Device name
PRECISION SPINAL CORD STIMULATION(SCS) SYSTEM
Applicant location
Valencia, CA
Received
Jan 30, 2017
Decided
Sep 8, 2017
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030017

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Cardiac Pacemakers, Inc. (CPI), A wholly owned subsidiary of Guidant Corporation, A wholly owned subsidiary of Boston Scientific Corporation, 4100 Hamline Avenue North, St. Paul, Minnesota 55112.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.